Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stocks to Watch: Citigroup, CME Group, Microsoft, Nokia, UBS

By

Monday's top stories and stocks with potential to move...

PrintPRINT

Stocks to watch for Monday, October 1, 2007:

  • Citigroup (C) said it expects to report a decline of about 60% in 3Q net income. CEO Charles Prince said in a statement the decline had been driven "by weak performance in fixed-income credit market activities, write-downs in leveraged loan commitments, and increases in consumer credit costs."
  • CME Group (CME) said it expects second-half operating expenses of $460 million to $470 million, or $425 million to $430 million excluding merger-related costs for restructuring and integration. The CME forecast capital expenditures in the range of $95 million to $105 million.
  • Johnson & Johnson (JNJ) and Novartis AG (NVS) could feel the effects of possible FDA enforcement actions against marketing unapproved prescription drugs containing pain killer hydrocodone.
  • Microsoft (MSFT) is moving to a more Web-based strategy as it is introducing a free service allowing Office software users to create and share documents over the Internet.
  • NetBank (NTBK) has been closed by the Office of Thrift Supervision because of high levels of mortgage-related losses. The FDIC was named receiver of the company's $2.5 billion in assets. ING Bank, part of ING Groep (ING) , will assume $1.5 billion of the insured deposits.
  • Nokia (NOK) is exploring a possible purchase of Navteq (NVT), which has a $7.61 bln market capitalization. Navteq is a leader in electronic mapping, which enables in-vehicle navigation devices and a new generation of mobile-phone applications used for shopping, emergency services and advertising.
  • Teva Pharmaceutical Industries (TEVA) said a federal appeals court denied Novartis AG's emergency motion for an injunction against Teva related to the companies' litigation over patent rights of Novartis' Famivir antiviral drug. As a result of the ruling, Teva can resume sales of famciclovir tablets, a generic version of Famivir.
  • UBS AG (UBS) reported a $3.4 bln loss in its fixed income portfolio, resulting in its first quarterly loss in nine years.. The company said it would cut 1,500 jobs in its investment bank.
  • UPS (UPS) and the Teamsters union have reportedly reached a tentative five-year agreement on raised parcel workers' wages and an increase into company provided pension and benefit contributions.


Market Update

  • Asian trading closed with the Nikkei +0.36%, Sensex +0.22% and Taiwan +0.13%. Hong Kong and China's markets were closed.
  • A quick check across the pond has the CAC -0.27%, DAX +0.01%, FTSE -0.05%, ATX +0.31%, Swiss Mkt. -0.20% and Stockholm -0.14%.
  • Crude oil is trading lower -0.21 to 81.45 while gold is higher +1.8 to 751.8 this morning.
No positions in stocks mentioned.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE